Gita Kwatra, PharmD, MBA, co-founder and CEO of the Glioblastoma Foundation, explains what happens to tumor tissue after brain surgery and how patients can ask their care team for genomic testing.
|Videos|July 26, 2017
The Cancer Moonshot and Parker Institute for Cancer Immunotherapy
Author(s)Ramy Ibrahim, M.D.
Ramy Ibrahim, M.D., vice president of Clinical Development at the Parker Institute for Cancer Immunotherapy discusses how the institute's mission aligns with the mission of the Cancer Moonshot.
Advertisement
Ramy Ibrahim, M.D., vice president of Clinical Development at the Parker Institute for Cancer Immunotherapy discusses how the institute's mission aligns with the mission of the Cancer Moonshot.
Both the Moonshot and the Parker Institute for Cancer Immunotherapy recognize that it is crucial to have enough resources to advance cancer sciences. The Parker Institute is working with top scientists and academic centers to reduce obstacles and barriers to immunotherapy research.
Advertisement
Related to this article
A breast surgeon explains why patients should raise lymphedema with their care team at the start of treatment, and how early detection can make it reversible.
A woman with stage 4 pancreatic cancer shares how a once-daily RAS inhibitor changed her energy, routine and time with family.
Brad Dugai and Russ Reed discuss symptom relief, skin-related side effects and challenges accessing Rasonque, a treatment for pancreatic cancer.
A nurse practitioner discusses how an app provides information on cancer treatments, potential side effects and preparing for medical appointments.
Final KEYNOTE-564 data show Keytruda after kidney cancer surgery lowered the risk of death by 30%. Dr. Toni Choueiri explains what it means for patients.
A physician emphasized how emotional support, reliable health information and caregiver involvement can encourage men to take a more proactive approach to prostate cancer screening and care.
Dr. Hope S. Rugo explains what KEYNOTE-B49 found about adding Keytruda to chemotherapy for PD-L1-positive, HR-positive, HER2-negative breast cancer.
Advertisement
Advertisement
Trending on CURE
1
What Is a Whipple Procedure? Pancreatic Cancer Surgery Explained
2
Glioblastoma Patients Can Request Genomic Testing on Their Tumor Tissue
3
Weight Loss With Pancreatic Cancer: Why It Happens and What Helps
4
Datroway Slows Brain Metastases in Triple-Negative Breast Cancer
5